Leng, Sean X.
Shaw, Albert C.
Funding for this research was provided by:
Milstein Medical Asian American Partnership Foundation (the Paul and Irma Milstein Program at Johns Hopkin Center on Aging and Immune Remodelings)
Article History
Received: 2 November 2023
Accepted: 8 November 2023
First Online: 29 November 2023
Declarations
:
: Not applicable.
: Sean Leng participated in Sanofi’s global meningococcal vaccination initiative and International Advisory Board on SARS-CoV-2 vaccine development and engaged in speaking for GSK on Shingrix vaccine. Albert Shaw has a research grant from Boerhinger-Ingelheim. Both Sean Leng and Albert Shaw serve on the Editorial Board of Immunity and Ageing.